• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体内有机阳离子噻嗪铵和亚砜噻嗪铵的肝脏分布及胆汁排泄

Hepatic disposition and biliary excretion of the organic cations thiazinamium and thiazinamium sulfoxide in rats.

作者信息

Neef K, Jonkman J H, Meijer D K

出版信息

J Pharm Sci. 1978 Aug;67(8):1147-50. doi: 10.1002/jps.2600670832.

DOI:10.1002/jps.2600670832
PMID:671255
Abstract

The disappearance from plasma and the excretion in bile of the monoquaternary thiazinamium (administered as the iodide) and one of its polar metabolites, thiazinamium sulfoxide (also administered as the iodide), were studied in the rat after intravenous injection to obtain more information on hepatic transport mechanisms for organic cations. Both compounds exhibited an extremely rapid plasma disappearance, partly due to a rapid liver uptake. After injection of thiazinamium iodide and thiazinamium sulfoxide iodide, 36 and 47%, respectively, of the administered dose were excreted in bile during 1 hr. TLC analysis of the bile showed at least two unidentified polar metabolites in addition to thiazinamium sulfoxide and only 3.8% unchanged thiazinamium after administration of thiazinamium iodide. The same metabolites were found after injection of thiazinamium sulfoxide iodide. Urinary excretion and intestinal secretion were 18 and 12%, respectively, for thiazinamium sulfoxide iodide and 27 and 9%, respectively, of the dose for thiazinamium iodide. It is concluded that, in spite of unequal physicochemical features, thiazinamium iodide and thiazinamium sulfoxide iodide differ only slightly in hepatic uptake and metabolism.

摘要

为了获取更多关于有机阳离子肝脏转运机制的信息,研究了大鼠静脉注射单季铵噻嗪铵(以碘化物形式给药)及其一种极性代谢物亚砜噻嗪铵(也以碘化物形式给药)后,它们从血浆中的消失情况以及在胆汁中的排泄情况。两种化合物在血浆中的消失都极快,部分原因是肝脏摄取迅速。注射碘噻嗪铵和碘亚砜噻嗪铵后,在1小时内分别有36%和47%的给药剂量经胆汁排泄。胆汁的薄层色谱分析表明,除了亚砜噻嗪铵外,至少还有两种未鉴定的极性代谢物,注射碘噻嗪铵后只有3.8%的噻嗪铵未发生变化。注射碘亚砜噻嗪铵后也发现了相同的代谢物。碘亚砜噻嗪铵的尿排泄和肠道分泌分别为18%和12%,碘噻嗪铵的剂量分别为27%和9%。得出的结论是,尽管碘噻嗪铵和碘亚砜噻嗪铵的物理化学特性不同,但它们在肝脏摄取和代谢方面仅略有差异。

相似文献

1
Hepatic disposition and biliary excretion of the organic cations thiazinamium and thiazinamium sulfoxide in rats.大鼠体内有机阳离子噻嗪铵和亚砜噻嗪铵的肝脏分布及胆汁排泄
J Pharm Sci. 1978 Aug;67(8):1147-50. doi: 10.1002/jps.2600670832.
2
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.季铵化合物甲硫酸噻嗪铵(Multergan)在人体中的代谢与排泄。I. 胃肠外给药
Pharm Weekbl Sci. 1982 Oct 22;4(5):122-8. doi: 10.1007/BF01959029.
3
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.季铵化合物甲硫酸噻嗪铵(Multergan)在人体中的代谢与排泄。II. 口服与直肠给药
Pharm Weekbl Sci. 1982 Oct 22;4(5):129-34. doi: 10.1007/BF01959030.
4
Hepatic first-pass effect of thiazinamium methylsulfate (N-methylpromethazine methylsulfate) in dogs.硫酸噻嗪铵(N-甲基异丙嗪甲基硫酸盐)在犬体内的肝首过效应。
J Pharm Sci. 1981 Aug;70(8):947-9. doi: 10.1002/jps.2600700831.
5
Hepatic uptake and biliary excretion of organic cations--I. Characterization of three new model compounds.有机阳离子的肝脏摄取和胆汁排泄——I. 三种新模型化合物的特性
Biochem Pharmacol. 1984 Dec 15;33(24):3977-90. doi: 10.1016/0006-2952(84)90011-x.
6
Hepatic uptake and biliary excretion of organic cations--II. The influence of ion pair formation.
Biochem Pharmacol. 1984 Dec 15;33(24):3991-4002. doi: 10.1016/0006-2952(84)90012-1.
7
Unequal disposition of enantiomers of the organic cation oxyphenonium in the rat isolated perfused liver.有机阳离子奥芬溴铵对映体在大鼠离体灌注肝脏中的分布不均。
J Pharm Pharmacol. 1989 Jan;41(1):27-31. doi: 10.1111/j.2042-7158.1989.tb06323.x.
8
Hepatic uptake and biliary excretion of d-tubocurarine and trimethyltubocurarine in the rat in vivo and in isolated perfused rat livers.大鼠体内及离体灌注大鼠肝脏中d-筒箭毒碱和三甲基筒箭毒碱的肝摄取及胆汁排泄
J Pharmacol Exp Ther. 1976 Jul;198(1):229-39.
9
First-pass effect after rectal administration of thiazinamium methylsulfate.直肠给药甲硫酸噻嗪铵后的首过效应。
J Pharm Sci. 1979 Jan;68(1):69-72. doi: 10.1002/jps.2600680121.
10
Structure-pharmacokinetics relationship of quaternary ammonium compounds. Elimination and distribution characteristics.季铵化合物的构效关系。消除与分布特征。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):103-10. doi: 10.1007/BF00512058.

引用本文的文献

1
Structure-pharmacokinetics relationship of quaternary ammonium compounds. Elimination and distribution characteristics.季铵化合物的构效关系。消除与分布特征。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):103-10. doi: 10.1007/BF00512058.
2
Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.季铵化合物甲硫酸噻嗪铵(Multergan)在人体中的代谢与排泄。I. 胃肠外给药
Pharm Weekbl Sci. 1982 Oct 22;4(5):122-8. doi: 10.1007/BF01959029.
3
Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.
载体介导的转运在药物肝脏分布和消除中的作用,特别涉及有机阳离子类别
J Pharmacokinet Biopharm. 1990 Feb;18(1):35-70. doi: 10.1007/BF01063621.